Related Experiment Video
Updated: Jan 28, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
Successes and challenges for preventing measles, mumps and rubella by vaccination
Bettina Bankamp1, Carole Hickman1, Joseph P Icenogle1
1Viral Vaccine Preventable Diseases Branch, Division of Viral Diseases, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, 30329, USA.
Abstract:
The measles, mumps and rubella (MMR) vaccine has an outstanding safety record and is highly efficacious. High coverage with MMR has led to the elimination of endemic measles, rubella, and congenital rubella syndrome in the US. The biggest challenges to global measles and rubella control and elimination are insufficient vaccination coverage globally and increasing hesitancy. Despite high two dose coverage rates, mumps has made a resurgence in the US and other countries. Mumps outbreaks have occurred primarily in close contact, high-density settings and most cases had received a second dose 10 or more years previously. Waning humoral immunity and antigenic variation of circulating wild-type mumps strains may play a role in the mumps resurgence.
Insights
The measles, mumps, and rubella (MMR) vaccine is safe and effective, eliminating diseases in the US. However, global vaccination gaps and mumps resurgence due to waning immunity and viral changes pose challenges.
Area of Science:
- Immunization
- Vaccinology
- Public Health
Background:
- The measles, mumps, and rubella (MMR) vaccine boasts an excellent safety profile and high efficacy.
- Widespread MMR vaccination has successfully eliminated endemic measles, rubella, and congenital rubella syndrome in the United States.
- Global challenges to measles and rubella control include inadequate vaccination coverage and vaccine hesitancy.
Purpose of the Study:
- To review the efficacy and safety of the MMR vaccine.
- To discuss challenges in global measles and rubella control.
- To explore reasons for the resurgence of mumps despite high vaccination rates.
Main Methods:
- Review of existing literature on MMR vaccine efficacy and safety.
- Analysis of global vaccination coverage data.
- Examination of epidemiological data on mumps outbreaks and potential contributing factors.
Main Results:
- High MMR coverage has led to disease elimination in the US.
- Mumps is resurging in the US and other countries, primarily in high-density settings.
- Waning immunity and antigenic variation in mumps strains are potential factors in the resurgence.
Conclusions:
- The MMR vaccine remains a critical tool for public health.
- Addressing global vaccination gaps and hesitancy is crucial for disease control.
- Further research into mumps immunity and viral evolution is needed to combat resurgence.
Related Concept Videos
Vaccinations
Ecological Succession
Cancer Prevention
Some...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Prevention of Further Absorption of Poison
Preventive Healthcare Services

